AKTEPE, O. H. Et Al. 2021. Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?. JOURNAL OF B.U.ON. , vol.26, no.5 , 2067-2073.

AKTEPE, O. H., ARDIÇ, F. S., YÜCE, D., GÜVEN, D. C., GÜNER, G., YILDIRIM, H. Ç., ... KILIÇKAP, S.(2021). Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?. JOURNAL OF B.U.ON. , vol.26, no.5, 2067-2073.

AKTEPE, OKTAY Et Al. "Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?," JOURNAL OF B.U.ON. , vol.26, no.5, 2067-2073, 2021

AKTEPE, OKTAY H. Et Al. "Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?." JOURNAL OF B.U.ON. , vol.26, no.5, pp.2067-2073, 2021

AKTEPE, O. H. Et Al. (2021) . "Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?." JOURNAL OF B.U.ON. , vol.26, no.5, pp.2067-2073.

@article{article, author={OKTAY HALİT AKTEPE Et Al. }, title={Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?}, journal={JOURNAL OF B.U.ON.}, year=2021, pages={2067-2073} }